FDA approves first generic Effexor extended release capsules for major depressive disorder
Jul 06, 2010
The Food and Drug Administration has approved the first generic version of Effexor XR capsules (venlafaxine hydrochloride) to treat major depressive disorder. Venlafaxine hydrochloride extended-release...
Clinical briefs for Tuesday, March 5
By
Kristen Fischer
Mar 05, 2024
Medicare Part D upped limitations on drugs, coverage … Several factors can predict urinary, fecal incontinence … Alternative pharmacies lack on generic drugs … Flu rising in central states as COVID,...
Clinical Briefs for Thursday, January 2
By
Alicia Lasek
Jan 01, 2020
First generics of blood thinner Eliquis approved… FDA receives $91 million funding increase for 2020 … Few pharmacies provide antibiotic disposal instructions, survey shows
Clinical Briefs for Monday, April 13
By
Alicia Lasek
Apr 12, 2020
More than 2,200 COVID-19 deaths in nursing homes … Lack of data, testing puts residents at risk of coronavirus: provider survey … More evidence found that ultrasound can aid in delivering future Alzheimer’s...
Doctor found guilty in $9.5M kickback case that targeted nursing home patients
By
Jessica R. Towhey
Sep 07, 2023
A Chicago-based doctor was convicted by a federal jury in a more than $9.5 million kickback scheme that targeted Medicare and Medicaid patients at nursing homes.
Combining two drugs may help ameliorate Alzheimer’s symptoms
By
Haymarket Media
Jan 23, 2004
Two drugs that act differently on the brain’s chemistry worked in tandem to help ameliorate Alzheimer’s disease, researchers reported in the Journal of the American Medical Association.
Pfizer mulls possible OTC switch for Lipitor
Aug 16, 2011
Pfizer is reportedly weighing an attempt at an over-the-counter switch for Lipitor – a move that could help the company recoup some of its losses when the $11 billion drug loses nationwide exclusivity...
Clinical briefs for Wed, Oct. 4
By
Kristen Fischer
Oct 04, 2023
Some injections don’t work for osteoarthritis in hands … Efforts to reduce generic, biosimilar drug prices largely lacking, report finds … Study to gauge lifestyle factors, brain health … Researchers...
Pharma company Teva to pay $27 million over charges of kickbacks to promote dangerous antipsychotic
By
Tim Mullaney
Mar 12, 2014
Teva Pharmaceuticals and subsidiary IVAX LLC have agreed to a $27.6 million settlement over charges that they paid kickbacks to a psychiatrist for putting nursing home residents on the antipsychotic drug...
Long-term care looks for leaders as healthcare industry adds jobs
By
McKnight's Staff
May 07, 2012
A new rise in healthcare jobs is good news for executives in senior care, an expert said Friday.